APA aipamena

Yamada, H., Kuro-o, M., Funazaki, S., Ishikawa, S., Kakei, M., & Hara, K. (2018). The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients with Type 2 Diabetes: An Observational Pilot Study. Int J Nephrol.

Chicago Style aipamena

Yamada, Hodaka, Makoto Kuro-o, Shunsuke Funazaki, San-e Ishikawa, Masafumi Kakei, and Kazuo Hara. "The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients With Type 2 Diabetes: An Observational Pilot Study." Int J Nephrol 2018.

MLA aipamena

Yamada, Hodaka, et al. "The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients With Type 2 Diabetes: An Observational Pilot Study." Int J Nephrol 2018.